Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'highly active antiretroviral therapy' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 117 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zinkernagel, C; Taffe, P; Rickenbach, M; Amiet, R; Ledergerber, B; Volkart, AC; Rauchfleisch, U; Kiss, A; Werder, V; Vernazza, P; Battegay, M
      Importance of mental health assessment in HIV-infected outpatients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Beinker, NK; Mayers, DL; Lange, CG; Valdez, H; Sitkins, J; Lemonnier, L; Chowdhry, TK; Lederman, MM
      Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Tozzi, V; Balestra, T; Galgani, S; Narciso, P; Sampaolesi, A; Antinori, A; Giulianelli, M; Serraino, I; Ippolito, G
      Changes in neurocognitive performance in a cohort of patients treated withHAART for 3 years

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Gebo, KA; Diener-West, M; Moore, RD
      Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Bangsberg, DR; Hecht, FM; Clague, H; Charlebois, ED; Ciccarone, D; Chesney, M; Moss, A
      Provider assessment of adherence to HIV antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Talal, AH; Monard, S; Vesanen, M; Zheng, ZY; Hurley, A; Cao, YZ; Fang, F; Smiley, L; Johnson, J; Kost, R; Markowitz, MH
      Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    8. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Zollner, B; Feucht, HH; Weitner, L; Adam, A; Schroter, M; Schafer, P; Laufs, R
      Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients

      JOURNAL OF CLINICAL VIROLOGY
    10. Geschwind, MD; Skolasky, RI; Royal, WS; McArthur, JC
      The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

      JOURNAL OF NEUROVIROLOGY
    11. Regazzi, MB; Seminari, E; Villani, P; Carriero, PL; Montagna, M; Marubbi, F; Maserati, R
      Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile

      JOURNAL OF CHEMOTHERAPY
    12. Muise, A; Arbess, G
      The risk of myocardial infarction in HIV-infected patients receiving HAART: a case report

      INTERNATIONAL JOURNAL OF STD & AIDS
    13. Yamamoto, Y; Yasuoka, A; Tachikawa, N; Teruya, K; Genka, I; Yamaguchi, M; Yasuoka, C; Kikuchi, Y; Yoneyama, A; Oka, S
      Two cases of long lasting bacteremia due to Mycobacetrium avium complex despite new macrolides-containing regimens in patients with acquired immunodeficiency syndrome

      INTERNAL MEDICINE
    14. Johnston, AM; Valentine, ME; Ottinger, J; Baydo, R; Gryszowka, V; Vavro, C; Weinhold, K; Clair, MS; McKinney, RE
      Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    15. Reed, JB; Briggs, JW; McDonald, JC; Freeman, WR; Morse, LS
      Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis - Long-term results in a small case series

      RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
    16. Lepri, AC; Phillips, AN; Monforte, AD; Castelli, F; Antinori, A; de Luca, A; Pezzotti, P; Alberici, F; Cargnel, A; Grima, P; Piscopo, R; Prestileo, T; Scalise, G; Vigevani, M; Moroni, M
      When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study

      AIDS
    17. Kirk, O; Mocroft, A; Pradier, C; Bruun, JN; Hemmer, R; Clotet, B; Miller, V; Viard, JP; Phillips, AN; Lundgren, JD
      Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir

      AIDS
    18. Ngo-Giang-Huong, N; Deveau, C; Da Silva, I; Pellegrin, I; Venet, A; Harzic, M; Sinet, M; Delfraissy, JF; Meyer, L; Goujard, C; Rouzioux, C
      Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

      AIDS
    19. Yamashita, TE; Phair, JP; Munoz, A; Margolick, JB; Detels, R; O'Brien, SJ; Mellors, JW; Wolinsky, SM; Jacobson, LP
      Immunologic and virologic response to highly active antiretroviral therapyin the Multicenter AIDS Cohort Study

      AIDS
    20. Dukers, NHTM; Goudsmit, J; de Wit, JBF; Prins, M; Weverling, GJ; Coutinho, RA
      Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection

      AIDS
    21. Sollitto, S; Mehlman, M; Youngner, S; Lederman, MM
      Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?

      AIDS
    22. Gharakhanian, S
      The HIV-associated lipodystrophy syndrome: Research, results, yet more questions

      AIDS
    23. Teixeira, L; Valdez, H; McCune, JM; Koup, RA; Badley, AD; Hellerstein, MK; Napolitano, LA; Douek, DC; Mbisa, G; Deeks, S; Harris, JM; Barbour, JD; Gross, BH; Francis, IR; Halvorsen, R; Asaad, R; Lederman, MM
      Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

      AIDS
    24. Mora, S; Sala, N; Bricalli, D; Zuin, G; Chiumello, G; Vigano, A
      Bone mineral loss through increased bone turnover in HIV-infected childrentreated with highly active antiretroviral therapy

      AIDS
    25. Patterson, BK; McCallister, S; Schutz, M; Siegel, JN; Shults, K; Flener, Z; Landay, A
      Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART

      AIDS
    26. Celentano, DD; Galai, N; Sethi, AK; Shah, NG; Strathdee, SA; Vlahov, D; Gallant, JE
      Time to initiating highly active antiretroviral therapy among HIV infectedinjection drug users

      AIDS
    27. Clumeck, N; Goebel, F; Rozenbaum, W; Gerstoft, J; Staszewski, S; Montaner, J; Johnson, M; Gazzard, B; Stone, C; Athisegaran, R; Moore, S
      Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA

      AIDS
    28. Bartlett, JA; DeMasi, R; Quinn, J; Moxham, C; Rousseau, F
      Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

      AIDS
    29. DeSilva, KE; Le Flore, DB; Marston, BJ; Rimland, D
      Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine

      AIDS
    30. Sonza, S; Mutimer, HP; Oelrichs, R; Jardine, D; Harvey, K; Dunne, A; Purcell, DF; Birch, C; Crowe, SM
      Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy

      AIDS
    31. Villani, P; Feroggio, M; Gianelli, L; Bartoli, A; Montagna, M; Maserati, R; Regazzi, MB
      Antiretrovirals: Simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay

      THERAPEUTIC DRUG MONITORING
    32. Pedro-Botet, ML; Modol, JM; Valles, X; Reynaga, E; Romeu, J; Juan, M; Sopena, N; Leal, MS
      Reduction of hematogenous infection in HIV positive patients following highly active antiretroviral therapy

      MEDICINA CLINICA
    33. Pellet, C; Chevret, S; Blum, L; Gauville, C; Hurault, M; Blanchard, G; Agbalika, F; Lascoux, C; Ponscarme, D; Morel, P; Calvo, F; Lebbe, C
      Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    34. Jolles, S; Tyrer, M; Johnson, M; Webster, D
      Long term recovery of IgG and IgM production during HIV infection in a patient with common variable immunodeficiency (CVID)

      JOURNAL OF CLINICAL PATHOLOGY
    35. Place, RJ; Gregorcyk, SG; Huber, PJ; Simmang, CL
      Outcome analysis of HIV-positive patients with anal squamous cell carcinoma

      DISEASES OF THE COLON & RECTUM
    36. Wei, CCY; Gardner, S; Rachlis, A; Pack, LL; Chan, CKN
      Risk factors for prophylaxis failure in patients receiving aerosol pentamidine for Pneumocystis carinii pneumonia prophylaxis

      CHEST
    37. Vaccher, E; Spina, M; di Gennaro, G; Talamini, R; Nasti, G; Schioppa, O; Vultaggio, G; Tirelli, U
      Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

      CANCER CYTOPATHOLOGY
    38. Vaccher, E; Spina, M; di Gennaro, G; Talamini, R; Nasti, G; Schioppa, O; Vultaggio, G; Tirelli, U
      Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

      CANCER
    39. Minkoff, H; Ahdieh, L; Watts, H; Greenblatt, RM; Schmidt, J; Schneider, M; Stek, A
      The relationship of pregnancy to the use of highly active antiretroviral therapy

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    40. Robinson, WR; Hamilton, CA; Michaels, SH; Kissinger, P
      Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    41. McDermott, AY; Shevitz, A; Knox, T; Roubenoff, R; Kehayias, J; Gorbach, S
      Effect of highly active antiretroviral therapy on fat, lean, and bone massin HIV-seropositive men and women

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    42. Miao, YM; Awad-El-Kariem, FM; Franzen, C; Ellis, DS; Muller, A; Counihan, HM; Hayes, PJ; Gazzard, BG
      Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    43. Hung, CC; Chen, MY; Hsieh, SM; Sheng, WH; Chang, SC
      Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: A 5-year prospective study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    44. Gehringer, H; Bogner, JR; Goebel, FD; Nitschko, H; von der Helm, K
      Sequence analysis of the HIV-1 protease coding region of 18 HIV-1-infectedpatients prior to HAART and possible implications on HAART

      JOURNAL OF CLINICAL VIROLOGY
    45. Nichols, WG; Boeckh, M
      Recent advances in the therapy and prevention of CMV infections

      JOURNAL OF CLINICAL VIROLOGY
    46. Villahermosa, ML; Thomson, M; de Parga, EV; Cuevas, MT; Contreras, G; Perez-Alvarez, L; Delgado, E; Manjon, N; Medrano, L; Najera, R
      Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load

      JOURNAL OF HUMAN VIROLOGY
    47. Koppel, K; Bratt, G; Eriksson, M; Sandstrom, E
      Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1infection

      INTERNATIONAL JOURNAL OF STD & AIDS
    48. Best, J; Althaus, C; Kersten, A; Theisen, A; Gantke, B
      Cessation of anti-cytomegalovirus maintenance therapy in AIDS patients with cytomegalovirus retinitis healed by highly active antiretroviral therapy

      OPHTHALMOLOGE
    49. Matsushita, S
      Current status and future issues in the treatment of HIV-1 infection

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    50. Murakami, T; Nakajima, M; Nakamura, T; Hara, A; Uyama, E; Mita, S; Matsushita, S; Uchino, M
      Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection

      INTERNAL MEDICINE
    51. Suarez, T; Reese, FL
      Coping, psychological adjustment, and complementary and alternative medicine use in persons living with HIV and AIDS

      PSYCHOLOGY & HEALTH
    52. Aukrust, P; Bjornsen, S; Lunden, B; Otterdal, K; Ng, EC; Ameln, W; Ueland, T; Muller, F; Solum, NO; Brosstad, F; Froland, SS
      Persistently elevated levels of von Willebrand factor antigen in HIV infection - Downregulation during highly active antiretroviral therapy

      THROMBOSIS AND HAEMOSTASIS
    53. Song, MK; Karavellas, MP; MacDonald, JC; Plummer, DJ; Freeman, WR
      Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy

      RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
    54. Ahuja, TS; Borucki, M; Grady, J
      Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    55. Deayton, JR; Wilson, P; Sabin, CA; Davey, CC; Johnson, MA; Emery, VC; Griffiths, PD
      Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy

      AIDS
    56. Kaufmann, GR; Bloch, M; Zaunders, JJ; Smith, D; Cooper, DA
      Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy

      AIDS
    57. Sabin, CA; Yee, TT; Devereux, H; Griffioen, A; Loveday, C; Phillips, AN; Lee, CA
      Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy

      AIDS
    58. Salmon-Ceron, D; Mazeron, MC; Chaput, S; Boukli, N; Senechal, R; Houhou, N; Katlama, C; Matheron, S; Fillet, AM; Gozlan, J; Leport, C; Jeantils, V; Freymuth, F; Costagliola, D
      Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

      AIDS
    59. Al-Harthi, L; Siegel, J; Spritzler, J; Pottage, J; Agnoli, M; Landay, A
      Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease

      AIDS
    60. Khanna, N; Klimkait, T; Schiffer, V; Irigoyen, J; Telenti, A; Hirschel, B; Battegay, M
      Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients

      AIDS
    61. Barreiro, P; Soriano, V; Blanco, F; Casimiro, C; de la Cruz, JJ; Gonzalez-Lahoz, J
      Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy

      AIDS
    62. Monforte, AD; Lepri, AC; Rezza, G; Pezzotti, P; Antinori, A; Phillips, AN; Angarano, G; Colangeli, V; De Luca, A; Ippolito, G; Caggese, L; Soscia, F; Filice, G; Gritti, F; Narciso, P; Tirelli, U; Moroni, M
      Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients

      AIDS
    63. Bangsberg, DR; Hecht, FM; Charlebois, ED; Zolopa, AR; Holodniy, M; Sheiner, L; Bamberger, JD; Chesney, MA; Moss, A
      Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population

      AIDS
    64. Clerici, M; Seminari, E; Suter, F; Castelli, F; Pan, A; Biasin, M; Colombo, F; Trabattoni, D; Maggiolo, F; Carosi, G; Maserati, R
      Different immunologic profiles characterize HIV infection in highly activeantiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia

      AIDS
    65. Torriani, FJ; Freeman, WR; Macdonald, JC; Karavellas, MP; Durand, DM; Jeffrey, DD; Meylan, PRA; Schrier, RD
      CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy

      AIDS
    66. Garrigue, I; Pellegrin, I; Hoen, B; Dumon, B; Harzic, M; Schrive, MH; Sereni, D; Fleury, H
      Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA

      AIDS
    67. den Brinker, M; Wit, FWNM; Wertheim-van Dillen, PME; Jurriaans, S; Weel, J; van Leeuwen, R; Pakker, NG; Reiss, P; Danner, SA; Weverling, GJ; Lange, JMA
      Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

      AIDS
    68. Kaufmann, GR; Zaunders, JJ; Cunningham, P; Kelleher, AD; Grey, P; Smith, D; Carr, A; Cooper, DA
      Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection

      AIDS
    69. Knuchel, MC; Speck, RF; Schlaepfer, E; Kuster, H; Ott, P; Gunthard, HF; Opravil, M; Cone, RW; Weber, R
      Impact of TNF alpha, LT alpha, Fc gamma RII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients

      AIDS
    70. Monari, C; Casadevall, A; Baldelli, F; Francisci, D; Pietrella, D; Bistoni, F; Vecchiarelli, A
      Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy

      AIDS
    71. Rutschmann, OT; Vernazza, PL; Bucher, HC; Opravil, M; Ledergerber, B; Telenti, A; Malinverni, R; Bernasconi, E; Fagard, C; Leduc, D; Perrin, L; Hirschel, B
      Long-term hydroxyurea in combination with didanosine and stavudine for thetreatment of HIV-1 infection

      AIDS
    72. Mocroft, A; Devereux, H; Kinloch-de-Loes, S; Wilson, D; Madge, S; Youle, M; Tyrer, M; Loveday, C; Phillips, AN; Johnson, MA
      Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population

      AIDS
    73. Hatano, H; Vogel, S; Yoder, C; Metcalf, JA; Dewar, R; Davey, RT; Polis, MA
      Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression

      AIDS
    74. Andreoni, A; Parisi, SG; Sarmati, L; Nicastri, E; Ercoli, L; Mancino, G; Sotgiu, G; Mannazzu, M; Trevenzoli, M; Tridente, G; Concia, E; Aceti, A
      Cellular proviral HIV-DNA decline and viral isolation in naive subjects with < 5000 copies/ml of HIV-RNA and > 500 x 10(6)/I CD4 cells treated with highly active antiretroviral therapy

      AIDS
    75. Rousseau, MC; Molines, C; Moreau, J; Delmont, J
      Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients

      ANNALS OF NUTRITION AND METABOLISM
    76. Tomasselli, AG; Heinrikson, RL
      Targeting the HIV-protease in AIDS therapy: a current clinical perspective

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    77. Radziwill, AJ; Kappos, L; Battegay, M; Steck, AJ
      Neurological complications of HIV infection

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    78. Rabkin, JG; Ferrando, SJ; Lin, SH; Sewell, M; McElhiney, M
      Psychological effects of HAART: A 2-year study

      PSYCHOSOMATIC MEDICINE
    79. Shingadia, D; Viani, RM; Yogev, R; Binns, H; Dankner, WM; Spector, SA; Chadwick, EG
      Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus

      PEDIATRICS
    80. Alsina, MM; Bulla, F; Conill, C; Mallolas, J; Perez-Cuevas, JB; Lecha, M
      Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma

      MEDICINA CLINICA
    81. Gutierrez, F; Molto, J; Escolano, C; Mora, A; Pasquau, F; Gregori, J; Nogueira, E
      Genotypic resistance to antiretroviral drugs in patients with therapeutic failure to highly active antiretroviral therapy

      MEDICINA CLINICA
    82. Maschke, M; Kastrup, O; Esser, S; Ross, B; Hengge, U; Hufnagel, A
      Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    83. Molina, A; Krishnan, AY; Nademanee, A; Zabner, R; Sniecinski, I; Zaia, J; Forman, SJ
      High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy

      CANCER
    84. Aboulafia, DM; Bundow, D; Waide, S; Bennet, C; Kerr, D
      Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    85. Palefsky, JM
      Anal squamous intraepithelial lesions: Relation to HIV and human papillomavirus infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    86. Ventura, G; Tacconelli, E; Tumbarello, M; Lucia, MB; Larocca, LM; Cauda, R
      Non-AIDS-defining neoplasms and HIV infection

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    87. Hutchinson, S; Courtney, R; Mulcahy, F; O'Connor, M; Mullaney, S; Kilbride, R
      Monitoring cytomegalovirus retinitis prevalence in an HIV-seropositive cohort: the assessment of improvements observed following the introduction of highly active antiretroviral triple therapy

      INTERNATIONAL JOURNAL OF STD & AIDS
    88. Berthold, HK; Parhofer, KG; Ritter, MM; Addo, M; Wasmuth, JC; Schliefer, K; Spengler, U; Rockstroh, JK
      Influence of protease inhibitor therapy on lipoprotein metabolism

      JOURNAL OF INTERNAL MEDICINE
    89. Postelmans, L; Gerard, M; Sommereijns, B; Caspers-Velu, L
      Discontinuation of maintenance therapy for CMV retinitis in AIDS patients on highly active antiretroviral therapy

      OCULAR IMMUNOLOGY AND INFLAMMATION
    90. Postelmans, L; Payen, MC; De Wit, S; Caspers-Velu, L
      Neovascularization of the optic disc after highly active antiretroviral therapy in an AIDS patient with cytomegalovirus retinitis - A new immune recovery-related ocular disorder?

      OCULAR IMMUNOLOGY AND INFLAMMATION
    91. Inui, K; Miyagawa, H; Sashihara, J; Miyoshi, H; Tanaka-Taya, K; Nishigaki, T; Teraoka, S; Mano, T; Ono, J; Okada, S
      Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection

      BRAIN & DEVELOPMENT
    92. De Paoli, P; Zanussi, S; Caggiari, L; Bortolin, MT; D'Andrea, M; Simonelli, C; Tirelli, U
      Kinetics of lymphokine production in HIV plus patients treated with highlyactive antiretroviral therapy and interleukin 2

      JOURNAL OF CLINICAL IMMUNOLOGY
    93. Berger, JR; Major, EO
      Progressive multifocal leukoencephalopathy

      SEMINARS IN NEUROLOGY
    94. Rodriguez-Rosado, R; Briones, C; Soriano, V
      Introduction of HIV drug-resistance testing in clinical practice

      AIDS
    95. Ibanez, A; Puig, T; Elias, J; Clotet, B; Ruiz, L; Martinez, MA
      Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients

      AIDS
    96. Martinon, F; Michelet, C; Peguillet, I; Taoufik, Y; Lefebvre, P; Goujard, C; Guillet, JG; Delfraissy, JF; Lantz, O
      Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy

      AIDS
    97. Saves, M; Vandentorren, S; Daucourt, V; Marimoutou, C; Dupon, M; Couzigou, P; Bernard, N; Mercie, P; Dabis, F
      Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998

      AIDS
    98. Orenstein, JM; Feinberg, M; Yoder, C; Schrager, L; Mican, JM; Schwartzentruber, DJ; Davey, RT; Walker, RE; Falloon, J; Kovacs, JA; Miller, KD; Fox, C; Metcalf, JA; Masur, H; Polis, MA
      Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient

      AIDS
    99. Christeff, N; Melchior, JC; de Truchis, P; Perronne, C; Nunez, EA; Gougeon, ML
      Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations

      AIDS
    100. Bower, M; Fox, P; Fife, K; Gill, J; Nelson, M; Gazzard, B
      Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

      AIDS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 23:08:12